SARS-CoV-2 virus: Vaccines in development
Author:
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Chinese Academy of Sciences
Publisher
Elsevier BV
Reference86 articles.
1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020
2. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020
3. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19;Juno;Nat. Med.,2020
4. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques;Shan;Cell Res,2020
5. A mouse model of SARS-CoV-2 infection and pathogenesis;Sun;Cell Host Microbe,2020
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany);Vaccine: X;2024-08
2. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations;International Immunopharmacology;2023-04
3. Recent advances in respiratory immunization: A focus on COVID-19 vaccines;Journal of Controlled Release;2023-03
4. A simple and effective aerosol pathogen disinfection test for a flowing air disinfector;Journal of Biosafety and Biosecurity;2023-03
5. Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era;Environment International;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3